United Kingdom· GB-APID-38242211000001104
Trecondi 1g powder for solution for infusion
A treosulfan product containing treosulfan, registered in United Kingdom by medac UK. The same ATC class is registered in 16 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Treosulfan is registered in 16 of 19 countries.
Countries holding a registration under ATC L01AB02 (treosulfan), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Treosulfan · ATC L01AB02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Treosulfan
- Manufacturer
- medac UK
- Country
- United Kingdom (GB)
- ATC code
- L01AB02
- ATC class
- Treosulfan
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin4037353019256
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Treosulfan in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTRECONDIMedac Gesellschaft für klinische Spezialpräparate m.b.H., Wedel
- BelgiumTrecondi 1 gMedac
- FinlandTrecondiMedac Gesellschaft Für Klinische Spezialpräparate mbH
- NetherlandsTrecondi 1 g poeder voor oplossing voor infusieMedac Gesellschaft für klinische Spezialpräparate mbH
- PolandTrecondimedac Gesellschaft fuer klinische Spezialpraeparate mbH
- SwedenTrecondi 1 g Pulver till infusionsvätska, lösningmedac Gesellschaft für klinische Spezialpräparate mbH
- NorwayTrecondiMedac - Gesellschaft für klinische Spezialpräparate Gmbh - Wedel
- FranceTRECONDI 1 g, poudre pour solution pour perfusionMEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE (ALLEMAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Treosulfan Tillomed
- Belgium · Treosulfan Tillomed
- Czechia · Treosulfan Tillomed
- Germany · Ovastat, Treosulfan Tillomed
- Denmark · Treosulfan Tillomed
- Spain · Treosulfano Zentiva
- Finland · Treosulfan Tillomed
- France · Treosulfan Tillomed
- Greece · Treosulfan Tillomed
- Ireland · Treosulfan Tillomed
- Iceland · Trecondi
- Liechtenstein · Trecondi
- Netherlands · Treosulfan Tillomed
- Norway · Trecondi, Treosulfan Tillomed
- Poland · Treosulfan Zentiva
- Portugal · Treossulfano Tillomed
- Romania · Treosulfan Tillomed
- Sweden · Treosulfan Tillomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99a99d55-1677-4269-a447-751ae2d3bd1f GET /v1/drugs/99a99d55-1677-4269-a447-751ae2d3bd1f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38242211000001104",
"desc": "Trecondi 1g powder for solution for infusion (medac UK)",
"form": "Powder for solution for injection",
"vpid": "41772211000001102",
"source": "dmd",
"vtm_id": "777827002",
"strength": "1 gram",
"substance": "Treosulfan",
"ingredient": "Treosulfan",
"supplier_code": "9241811000001108"
}See everything about treosulfan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.